Skip to content

US Physical Therapy

US · USPH #3098 by market cap Listed 1970
82.96 -0.67 -0.80%
Live - 5344 symbols - heartbeat 271s ago · 2026-10-08 04:36
Pre-market 82.14 -0.99%
After-hours 82.96 0.00%
Market cap
1.24B
P/B
2.76
EPS
1.42
Reader sentiment Are you bullish or bearish on USPH?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions decreased by 2 in the most recent period (2026/Q3).
  • Total institutional ownership fell 0.5 percentage points.

Institutional ownership

Held by institutions
109.98% -0.52pp
Institutions
270 -2
As of
2026/Q3 vs. prior period

Ownership vs. money flow

Aligned

Institutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Holder types

Mutual Fund98.59%
Hedge Fund4.97%
Public Company3.76%
Individual/Insider2.57%
Government Pension Fund1.05%
Private Company0.91%
Family Office/Trust0.30%
VC/PE Fund0.30%

Top holders as of 2026-06-30

BlackRock 15.17% · 2.26M sh
Bahl & Gaynor LLC 5.77% · 861.57K sh
Kayne Anderson Rudnick Investment Management, LLC 5.67% · 846.67K sh
Copeland Capital Management, LLC 5.64% · 841.54K sh
Vanguard Capital Management, LLC 5.23% · 780.05K sh
State Street Global Advisors 4.74% · 707.19K sh
Neuberger Berman Investment Advisers LLC 4.01% · 598.89K sh
Eaton Vance Management 3.80% · 566.64K sh
American Century Investment Management 3.74% · 558.82K sh
SouthernSun Asset Management, LLC 3.54% · 527.77K sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 22 buys · 25 sells

NameRoleStake
Christopher Reading Chief Executive Officer 0.93%
Eric Williams Chief Operating Officer - East 0.27%
Graham Reeve Chief Operating Officer - West 0.19%
Carey Hendrickson Chief Financial Officer 0.19%
Kathleen Gilmartin Independent Director 0.18%
Richard Binstein General Counsel 0.16%
Reginald Swanson Independent Director 0.15%
Bernard Harris Independent Director 0.14%
Michael Mayrsohn Director 0.12%
Anne Motsenbocker Independent Director 0.07%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-09-30 Myra Davis Director Other Acquisition +1,210 --
2026-09-13 Nchacha Etta Chief Financial Officer Other Acquisition +6,831 --
2026-09-10 Peter Minan Independent Director Open Market Acquisition +6 $66.50–79.00
2026-08-19 Richard Binstein General Counsel Sale to Issuer -450 $78.00
2026-08-19 Eric Williams Chief Operating Officer - East Sale to Issuer -714 $78.00
2026-08-19 Graham Reeve Chief Operating Officer - West Sale to Issuer -762 $78.00
2026-08-19 Jason Curtis Senior Vice President of Finance & Accounting Sale to Issuer -40 $78.00
2026-06-08 Peter Minan Independent Director Open Market Acquisition +780 $61.50–63.14
2026-05-19 Graham Reeve Chief Operating Officer - West Sale to Issuer -762 $62.24
2026-05-19 Jason Curtis Senior Vice President of Finance & Accounting Sale to Issuer -40 $62.24
2026-05-18 Bernard Harris Independent Director Other Acquisition +2,306 --
2026-05-18 Kathleen Gilmartin Independent Director Other Acquisition +2,306 --
2026-05-18 Reginald Swanson Independent Director Other Acquisition +2,306 --
2026-05-18 Peter Minan Independent Director Other Acquisition +2,306 --
2026-05-18 Peter Minan Independent Director Initial Statement of Beneficial 0 --
2026-05-18 Anne Motsenbocker Independent Director Other Acquisition +2,306 --
2026-04-26 Jason Curtis Senior Vice President of Finance & Accounting Initial Statement of Beneficial 0 --
2026-03-10 Graham Reeve Chief Operating Officer - West Open Market Disposition -662 $78.86
2026-03-08 Carey Hendrickson Chief Financial Officer Sale to Issuer -10,000 --
2026-03-08 Graham Reeve Chief Operating Officer - West Open Market Disposition -1,808 $78.52–82.25

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-10-08 04:36:53 · For reference only, not investment advice and not tailored to your situation.